Biosimilar Reduction. If a Biosimilar Product to a Product is sold in any country in the Territory during the Product Royalty Term for such Product and country, the Product Royalties payable with respect to such Product in such country will be reduced by [***] for the remainder of such Product Royalty Term.
Appears in 9 contracts
Samples: Selected Product License Agreement (Artiva Biotherapeutics, Inc.), Selected Product License Agreement (Artiva Biotherapeutics, Inc.), Selected Product License Agreement (Artiva Biotherapeutics, Inc.)
Biosimilar Reduction. If a Biosimilar Product to a Product is sold in any country in the Territory during the Product Royalty Term for such Product and country, the Product Royalties payable with respect to such Product in such country will be reduced by by[***] for the remainder of such Product Royalty Term.
Appears in 1 contract
Samples: Selected Product License Agreement (Artiva Biotherapeutics, Inc.)
Biosimilar Reduction. If a Biosimilar Product to a Licensed Product is sold in any country in the Territory Licensed Territories during the Product Royalty Term for such Licensed Product and country, the Product Royalties payable with respect to such Licensed Product in such country will be reduced by [***] fifty percent (50%) for the remainder of such Product Royalty Term.
Appears in 1 contract
